[Open question to those responsible for the measles-mumps-rubella vaccination program].
Gaillet
R P
RP
D001291:Attitude of Health Personnel; D001294:Attitude to Health; D002648:Child; D002675:Child, Preschool; D003256:Community Participation; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008458:Measles Vaccine / Q000627:therapeutic use*; D022542:Measles-Mumps-Rubella Vaccine; D009108:Mumps Vaccine / Q000627:therapeutic use*; D012411:Rubella Vaccine / Q000627:therapeutic use*; D013557:Switzerland
D004338:Drug Combinations; D008458:Measles Vaccine; D022542:Measles-Mumps-Rubella Vaccine; D009108:Mumps Vaccine; D012411:Rubella Vaccine
Question ouverte aux responsables du programme de vaccination ROR.